![]() BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions. | ||
Founding Date | Founding Date 1929 | Founding Date 1997 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more |
Employees | Employees 5,358 | Employees 3,0015% increase |
Valuation ($) | Valuation ($) 10.2 b | Valuation ($) 13.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $3.2b (FY, 2025) |
Cost of goods | Cost of goods €659.1m (FY, 2025) | Cost of goods $717.4m (FY, 2025) |
Gross profit | Gross profit €3.3b (FY, 2025) | Gross profit $2.5b (FY, 2025) |
Net income | Net income €445.1m (FY, 2025) | Net income $348.9m (FY, 2025) |

BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.
View company